XML 18 R27.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2019

Schedule of estimated useful lives of the assets

Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates:


Computers and peripheral equipment		33%
Office furniture and equipment		6% – 20% (mainly 15%)
Leasehold improvements		Over the shorter of the term of the lease, or the useful life of the assets

Schedule of remaining performance obligations which are expected to be satisfied and recognized in future periods

The following table represents the remaining performance obligations as of December 31, 2019, which are expected to be satisfied and recognized in future periods:


	Year Ending December 31,
					2022 and
	2020		2021		thereafter

Product	$	3,896	$	16	$	—
Services		29,642		5,654		4,022

	$	33,538	$	5,670	$	4,022

Schedule of components of AOCI

The components of AOCI were as follows:


	Unrealized
	gains (losses)
	on available-		Unrealized
	for-sale		gains (losses)
	marketable		on cash flow
	securities		hedges		Total

Balance as of January 1, 2019	$	(32)	$	(244)	$	(276)

Other comprehensive income before reclassifications		32		535		567
Amounts reclassified from AOCI		—		(291)		(291)
Other comprehensive income		32		244		276

Balance as of December 31, 2019	$	—	$	—	$	—

Schedule of weighted-average assumptions

Fair values were estimated using the following weighted-average assumptions (annualized percentages):


	Year Ended December 31,
	2019	2018	2017

Dividend yield	1.13%-1.64%	0%-2.66%	0%
Expected volatility	38.08%-39.34%	37.74%-41.72%	41.78%-47.25%
Risk-free interest	1.66%-2.59%	2.40%-3.06%	1.81%-2.14%
Expected life	4.75-5.21 years	4.78-5.27 years	4.77-5.28 years

Schedule of total share-based compensation expenses

The total share-based compensation expenses relating to all of the Company’s share-based awards recognized for the years ended December 31, 2019, 2018 and 2017 were included in items of the consolidated statements of operations, as follows:


	Year Ended December 31,
		2019		2018	2017

Cost of revenues	$	183	$	186	$	84
Research and development expenses, net		937		651		383
Selling and marketing expenses		2,171		1,238		1,024
General and administrative expenses		2,001		1,212		816

Total share-based compensation expenses	$	5,292	$	3,287	$	2,307